D.C. Mun. Regs. tit. 22-C, § 5903
Cultivation Center and Manufacturer Reports
Effective Feb 25, 2026Authority: Section 14 of the Legalization of Marijuana for Medical Treatment Initiative of 1999, effective July 27, 2010 (D.C. Law 18 210; D.C. Official Code § 7 1671.13); and Mayor’s Order 2020-099, dated September 30, 2020. Source: Notice of Emergency and Third Proposed Rulemaking published at 58 DCR 3299 (April 15, 2011)[EXPIRED]; as amended by Notice of Emergency and Fourth Proposed Rulemaking published at 58 DCR 7207 (August 12, 2011)[EXPIRED]; as amended by Notice of Final Rulemaking published at 58 DCR 10128, 10216 (December 2, 2011); as amended by Final Rulemaking published at 71 DCR 002388 (March 8, 2024); as amended by Final Rulemaking published at 73 DCR 002136 (February 20, 2026).District of Columbia, Office of the Secretary
5903.1 Cultivation center and manufacturer licensees shall, on or before the thirtieth (30th) day of July and January, furnish to the Board on a form to be prescribed by the Board a statement under oath showing the following information:
- (a) The quantity of medical cannabis or medical cannabis product manufactured during the preceding six (6) months;
- (b) The quantity of each medical cannabis or medical cannabis product sold during the preceding six (6) months;
- (c) The quantity of paraphernalia manufactured during the preceding six (6) months;
- (d) The quantity and price of paraphernalia sold during the preceding six (6) months;
- (e) The amount of medical cannabis or medical cannabis products destroyed or disposed of during the preceding six (6) months;
- (f) Certification from MPD that medical cannabis that was cultivated or the medical cannabis products were relinquished for destruction or disposal;
- (g) The total expenditures for manufacturing medical cannabis or medical cannabis products during the preceding six (6) months;
- (h) The total amount of sales of medical cannabis or medical cannabis products during the preceding six (6) months;
- (i) The licensee's gross revenue based upon its medical cannabis or medical cannabis product sales during the preceding six (6) months;
- (j) The amount of sales tax reported to OTR during the preceding six (6) months;
- (k) The quantity of medical cannabis or medical cannabis products still available for sale at the establishment on the date the report is filed with the Board;
- (l) The name, address, home telephone number, and date of birth of each current employee; and
- (m) An affidavit executed by an individual licensee, partner of an applicant
partnership, or the appropriate officer of an applicant corporation, attesting to the truth of the submitted report.
SOURCE: Notice of Emergency and Third Proposed Rulemaking published at 58 DCR 3299 (April 15, 2011)[EXPIRED]; as amended by Notice of Emergency and Fourth Proposed Rulemaking published at 58 DCR 7207 (August 12, 2011)[EXPIRED]; as amended by Notice of Final Rulemaking published at 58 DCR 10128, 10216 (December 2, 2011); as amended by Final Rulemaking published at 71 DCR 002388 (March 8, 2024); as amended by Final Rulemaking published at 73 DCR 002136 (February 20, 2026).